| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | KIN001-102 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0009 |
| mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0009 |
| mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0009 |
| mRNA | AZD1480 | CTRPv2 | pan-cancer | AAC | 0.22 | 0.0009 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | -0.21 | 0.001 |
| mRNA | selumetinib:UNC0638 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.13 | 0.001 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | -0.2 | 0.001 |
| mRNA | RG-108 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.001 |
| mRNA | Vorinostat | GDSC1000 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | PFI-1 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.001 |